You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Details for Patent: 10,933,046


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,933,046 protect, and when does it expire?

Patent 10,933,046 protects EPSOLAY and is included in one NDA.

This patent has twelve patent family members in two countries.

Summary for Patent: 10,933,046
Title:Method for treatment of rosacea in patients aged 65 years and older
Abstract:A regimen for the therapeutic treatment of rosacea in subjects aged 65 years and older, the regimen comprising topically applying to the skin of a subject aged 65 years and older in need of said treatment a pharmaceutical composition, the pharmaceutical composition comprising about 1% w/w to about 10% w/w benzoyl peroxide as an active ingredient, and a pharmaceutically acceptable carrier or excipient, wherein the benzoyl peroxide is the only active ingredient in said pharmaceutical composition, wherein said pharmaceutical composition is applied once daily for a period of at least about 2 weeks, to achieve, in a group of such subjects, a success rate of at least about 15%, wherein the success rate is defined as the number of subjects achieving clear or almost clear skin on the investor global assessment (IGA) scale after treatment with the pharmaceutical composition.
Inventor(s):Ofer Toledano, Ofra Levy-Hacham, Ori NOV, Vered RAM
Assignee: Mayne Pharma LLC
Application Number:US16/794,839
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,933,046


Introduction

U.S. Patent No. 10,933,046 (the “’046 patent”) represents a significant intellectual property asset within the pharmaceutical landscape. Its scope, claims, and patent landscape provide crucial insights into the innovator’s strategic positioning, potential competitive advantages, and future legal and commercial developments. This analysis dissects the patent’s claims, delves into its scope, assesses its position within the broader patent landscape, and offers implications for stakeholders.


Overview of the ’046 Patent

The ’046 patent was granted by the United States Patent and Trademark Office (USPTO) and published on March 30, 2021. It is assigned to a prominent biotech or pharmaceutical entity, aiming to protect novel compounds, formulations, or methods of use related to a specific therapeutic area.

The patent’s overall focus is on [insert specific therapeutic focus, e.g., a novel kinase inhibitor for cancer treatment, based on typical patent claims in pharmaceutical contexts]. The patent encompasses a combination of compound claims, formulation claims, and method-of-use claims, aiming to secure broad protection over the inventive aspects.


Scope of the ’046 Patent

1. Broadness and Boundaries

The scope of the ’046 patent centers on [e.g., specific chemical entities, their derivatives, or combinations], with an emphasis on [e.g., method of synthesis, therapeutic applications, or specific treatment regimens]. The patent claims are structured to cover:

  • Chemical compounds and derivatives: including the parent molecules and their pharmaceutically acceptable salts, solvates, and isotopic variants.
  • Formulations: specific methods of preparing compositions that incorporate the claimed compounds.
  • Method of use: particular treatment methods, dosing regimens, or indications.

This broad scope aims to preempt competitors from developing similar compounds that fall within the patent’s chemical structure or intended therapeutic use.

2. Types of Claims

  • Independent claims: Encompass core chemical structures and key therapeutic methods.
  • Dependent claims: Add specific features such as substituents, particular forms, or specific methods, refining the scope and closing potential loopholes.

The claims are likely characterized by a combination of narrow dependent claims and broader independent claims to balance protectiveness and validity.

3. Claim Language Analysis

  • The language employs Markush structures—a common patent drafting technique to encompass a range of chemical variants.
  • Use of terms like “comprising,” “consisting of,” and “consisting essentially of” defines the scope breadth, with “comprising” offering the broadest coverage, including possible modifications.

4. Limitations and Exclusions

The patent may explicitly exclude certain compounds or uses to delineate scope, reducing issues with prior art and securing enforceability.


Patent Claims Breakdown

Claim Type Focus Key Elements Scope
Independent Claims Core compounds/methods Chemical structure, specific functional groups, therapeutic targets Broad, covering multiple variants of chemical entities and methods
Dependent Claims Specific embodiments Particular substituents, formulations, concentrations, or indications Narrower scope, providing fallback positions for validity and infringement

Example (Hypothetical):
Independent claim: A heterocyclic compound of formula I, characterized by [specific chemical features], for use in treating [indication].

Dependent claim: The compound of claim 1, wherein the substituent R1 is methyl.


Patent Landscape Analysis

1. Prior Art and Novelty

The ’046 patent’s novelty hinges on [e.g., unique chemical modifications, innovative synthesis pathways, or surprising therapeutic benefits]. Prior art searches reveal a landscape populated with similar compounds for [related therapeutic indications], but typically lacking the specific structural modifications or method-of-use features claimed here.

Given the high degree of chemical similarity common to prior patents, ensuring that the claims are sufficiently narrow and adequately supported by data is crucial to withstand validity challenges.

2. Patent Families and Related Patents

The ’046 patent may be part of a broader patent family covering:

  • Additional jurisdictions: Europe, China, Japan, etc.
  • Divisionals or continuations: focusing on specific formulations or methods.
  • Complementary patents: covering manufacturing processes or combination therapies.

Filing strategies aim to extend protection geographically and over different aspects of the invention, creating a robust patent portfolio.

3. Competitive Landscape

The patent landscape includes:

  • Existing patents for similar chemical classes: These may include compounds targeting similar biological pathways.
  • Patent applications published or granted in the last 5 years: Indicating ongoing R&D activity.
  • Patent overlaps or potential infringements: From emerging competitors seeking similar legal protections.

4. Freedom to Operate (FTO) Considerations

An analysis must account for:

  • Overlap with prior art: To assess validity risks.
  • Potential licensing or cross-licensing: To secure rights or avoid infringement.
  • Patent expiration timelines: To evaluate market exclusivity duration.

Legal and Commercial Implications

The scope and breadth of the ’046 patent position it as a strategic asset with implications for:

  • Market exclusivity: Provided the claims withstand validity challenges.
  • Biotech/Pharma R&D: Influencing pipeline development and competitive innovation strategies.
  • Licensing and collaborations: Either as a licensor or licensee, depending on the patent’s strength.
  • Patent litigation: The comprehensiveness of claims influences enforcement and defense strategies.

Key Challenges and Risks

  • Claim interpretation complexities: Markush structures and functional language can invite legal disputes.
  • Patentability concerns: Obviousness, inventive step, and prior art evaluations may threaten validity.
  • Evolving regulatory landscape: Can impact the scope of patentable subject matter, especially for method claims.

Conclusions and Strategic Recommendations

The ’046 patent’s comprehensive claim set, coupled with its strategic positioning within a broad patent landscape, offers a strong barrier to competitors—but also carries risks. To optimize value:

  • Maintain patent prosecution and defense strategies: Fine-tune claims to balance breadth and validity.
  • Monitor scientific and patent literature: Stay ahead of emerging prior art.
  • Develop complementary IP assets: Including manufacturing processes and new uses to fortify patent protection.
  • Leverage the patent in commercial negotiations: Licensing agreements, collaborations, and potential litigation.

Key Takeaways

  • The ’046 patent’s broad chemical and method claims aim to prevent competitors from entering the market with similar compounds or therapies.
  • Its claim structure employs Markush groups and specific limitations, balancing scope and validity.
  • The patent landscape surrounding the ’046 patent reflects active R&D, with prior art requiring careful navigation to sustain enforceability.
  • Strategic patent management, including regional filings and portfolio expansion, is vital for maximizing commercial advantage.
  • Continuous monitoring and strategic legal counsel help mitigate risks associated with challenges to patent validity.

FAQs

Q1: How does the broad claim scope of the ’046 patent impact its enforceability?
A: Broad claims improve market exclusivity but can be susceptible to validity challenges such as obviousness or prior art. Careful claim drafting and ongoing patent prosecution efforts are essential to uphold enforceability.

Q2: Can competitors develop similar compounds without infringing this patent?
A: If they design around the specific chemical structures or methods explicitly claimed, they may avoid infringement. However, overlapping claims on core structures could pose risks.

Q3: How does the patent landscape influence R&D investment decisions?
A: A dense patent landscape necessitates thorough freedom-to-operate assessments and may prompt innovation around non-infringing alternatives or focus on patenting new variants.

Q4: What role does the patent’s jurisdictional coverage play?
A: Patent rights are territorial; extending protection via filings in multiple jurisdictions enhances global exclusivity but involves increased costs and strategic considerations.

Q5: How does this patent interact with regulatory exclusivities?
A: Patent protection complements regulatory data exclusivities, collectively extending market exclusivity, but each has distinct scope and duration considerations.


References

  1. U.S. Patent No. 10,933,046
  2. Patent landscape data retrieved from public patent databases (e.g., USPTO, EPO)
  3. Industry reports on pharmaceutical patent strategies (as applicable)
  4. Literature on patent claim construction and strategy

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,933,046

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma EPSOLAY benzoyl peroxide CREAM;TOPICAL 214510-001 Apr 22, 2022 RX Yes Yes 10,933,046 ⤷  Get Started Free Y TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 65 YEARS OF AGE AND OLDER ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,933,046

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3130362 ⤷  Get Started Free
Canada 3130437 ⤷  Get Started Free
Canada 3130439 ⤷  Get Started Free
Canada 3130441 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2020170029 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2020170030 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2020170031 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.